Document Actions
The Clinical Cancer Letter Archive
August 2010, Vol. 33 No. 8
Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer. Olaparib, A PARP Inhibitor, Reduced Tumor Size In Advanced Ovarian Cancer in Phase II Trial. Brothers Of Prostate Cancer Patients At Higher Risk Of Diagnosis. Use Of Estrogen Alone Didn't Increase Risk Of Lung Cancer In WHI. Two Avastin Trials Show Overall Survival Benefit In Advanced Lung Cancer. Elderly Patients Fail To Receive Newer Therapy For CML. Radiation To Stem Cell Niche Improved PFS For Glioblastoma. NCI-Approved Cooperative Group Trials Listed.
To download, subscribe to the newsletter or sign up for a one day pass.
July 2010, Vol. 33 No. 7
Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds. ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer. Study Finds Half Of Early Breast Cancer Patients Complete Full Hormone Regimen. NCI-approved trials listed.
To download, subscribe to the newsletter or sign up for a one day pass.
June 2010, Vol. 33 No. 6
Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting. Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older.
To download, subscribe to the newsletter or sign up for a one day pass.
May 2010, Vol. 33 No. 5
Screening Mammograms In Young Women Have Low Accuracy, Detect Few Cancers. Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds. AE-941 Shark Cartilage Doesn't Improve Lung Cancer Survival.
To download, subscribe to the newsletter or sign up for a one day pass.
April 2010 Vol. 33 No. 4
AACR Meeting: Trial Links Potential Biomarkers To Drugs For Lung Cancer. Longer Followup Of STAR Finds Fewer Side Effects For Raloxifene. Controlling Diabetes Would Reduce Risk Of Liver Cancer. Statins Don't Prevent Colorectal Adenomas.
To download, subscribe to the newsletter or sign up for a one day pass.
March 2010, Vol. 33 No. 3
Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer. Study Validates Use Of PCA3 Urine Test For Prostate Cancer. Phase III Study Finds Hormone Therapy Plus Radiation Improves Survival for Early Prostate Cancer. Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer. For Early Breast Cancer Spread To One Node, No Benefit Seen For Radiation. Few Breast Cancer Patients May Benefit From Contralateral Mastectomy, Study Says.
To download, subscribe to the newsletter or sign up for a one day pass.
February 2010, Vol. 33 No. 2
Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis, Breast Cancer Death. Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC. Symptoms Not Useful For Early-Stage Ovarian Cancer Detection.
To download, subscribe to the newsletter or sign up for a one day pass.
January 2010, Vol. 33 No. 1
Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer. New Tests In Development For Colorectal, Pancreatic Cancers. Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds. Avastin Improves PFS Compared To Chemotherapy Alone.
To download, subscribe to the newsletter or sign up for a one day pass.
December 2009, Vol. 32 No. 12
ASCO Annual Report Names Significant Clinical Research Advances Of 2009. Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial for Multiple Myeloma. Tykerb Plus Herceptin Better Than Monotherapy For Breast Cancer. Bisphosphonates May Reduce Recurrent Breast Cancer. Cervical Cancer Screening Can Be Done Later, Less Often. Study Finds No Benefit To Cetuximab In Early Stage Colon Cancer.
To download, subscribe to the newsletter or sign up for a one day pass.
November 2009, Vol. 32 No. 11
Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients. High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer. ASCO Updates Lung Cancer Treatment Guideline. Nicotine Patch-Lozenge Combination Best For Smoking Cessation, Study Finds. Higher HDL Associated With Decreased Risk of Cancer.
To download, subscribe to the newsletter or sign up for a one day pass.
October 2009, Vol. 32 No. 10
Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues. Cancer Centers Begin Free Genetic Tumor Testing Project For Lung Cancer Patients. Study Suggests New Protocol For Rare Pediatric Brain Tumor. Recent FDA Drug Approvals and NCI Cooperative Group Trials Listed.
To download, subscribe to the newsletter or sign up for a one day pass.
September 2009, Vol. 32 No. 9
TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma. PARP Inhibitor In Trial For Patients With BRCA1 And 2 Mutations. Vanderbilt Seeks Lung Cancer Patients Who Never Smoked For Web-Based Study. Colorectal Cancer Screening Programs Could Cut Future Treatment Costs. NCI Cooperative Group Trials Listed.
To download, subscribe to the newsletter or sign up for a one day pass.
Forgot your password?